$1.62
-0.12-6.90%
At close: -
$1.63
0.010.62%
After Hours: 7:59 PM EDT
Comments
Loading...
C4 Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CCCC | Benzinga
C4 Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 16
EPS Estimate
$-0.420
Quarterly Revenue Estimate
$2.95M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$35.58M
Analyze the earnings history of C4 Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics | -$0.26 | — | — | — | $12.01M | — | — | — | 07/31/2025 | Get Alert |
| CCCC | C4 Therapeutics | -$0.41 | -$0.42 | — | — | $3.04M | $2.95M | — | — | 05/16/2025 | Get Alert |
| CCCC | C4 Therapeutics | -$0.68 | -$0.37 | -$0.49 | -32.43% | $3.26M | $3.60M | $5.18M | 43.81% | 02/27/2025 | Get Alert |
| CCCC | C4 Therapeutics | -$0.55 | -$0.38 | -$0.35 | 7.89% | $11.07M | $4.60M | $15.36M | 233.96% | 10/31/2024 | Get Alert |
| CCCC | C4 Therapeutics | -$0.73 | -$0.37 | -$0.26 | 29.73% | $2.66M | $4.78M | $12.01M | 151.17% | 08/01/2024 | Get Alert |
| CCCC | C4 Therapeutics | -$0.71 | -$0.35 | -$0.41 | -17.14% | $3.76M | $8.10M | $3.04M | -62.48% | 05/08/2024 | Get Alert |
| CCCC | C4 Therapeutics | -$0.76 | -$0.68 | -$0.68 | 0.00% | $2.85M | $3.19M | $3.26M | 2.23% | 02/22/2024 | Get Alert |
| CCCC | C4 Therapeutics | -$0.65 | -$0.66 | -$0.55 | 16.67% | $6.75M | $5.46M | $11.07M | 102.78% | 11/01/2023 | Get Alert |
| CCCC | C4 Therapeutics | -$0.56 | -$0.69 | -$0.73 | -5.80% | $13.83M | $6.44M | $2.66M | -58.63% | 08/08/2023 | Get Alert |
| CCCC | C4 Therapeutics | -$0.65 | -$0.75 | -$0.71 | 5.33% | $7.65M | $5.46M | $3.76M | -31.15% | 05/04/2023 | Get Alert |
| CCCC | C4 Therapeutics | -$0.31 | -$0.74 | -$0.76 | -2.70% | $20.09M | $7.81M | $2.85M | -63.46% | 02/23/2023 | Get Alert |
| CCCC | C4 Therapeutics | -$0.51 | -$0.67 | -$0.65 | 2.99% | $8.50M | $9.07M | $6.75M | -25.53% | 11/03/2022 | Get Alert |
| CCCC | C4 Therapeutics | -$0.51 | -$0.69 | -$0.56 | 18.84% | $9.78M | $7.64M | $13.83M | 81.07% | 08/04/2022 | Get Alert |
| CCCC | C4 Therapeutics | -$0.49 | -$0.58 | -$0.65 | -12.07% | $7.43M | $8.05M | $7.65M | -4.92% | 05/05/2022 | Get Alert |
| CCCC | C4 Therapeutics | -$3.45 | -$0.58 | -$0.31 | 46.55% | $8.26M | $7.08M | $20.09M | 183.80% | 02/24/2022 | Get Alert |
| CCCC | C4 Therapeutics | -$17.55 | -$0.59 | -$0.51 | 13.56% | $8.45M | $7.61M | $8.50M | 11.70% | 11/10/2021 | Get Alert |
| CCCC | C4 Therapeutics | — | -$0.59 | -$0.51 | 13.56% | — | $6.02M | $9.78M | 62.48% | 08/11/2021 | Get Alert |
| CCCC | C4 Therapeutics | — | -$0.69 | -$0.49 | 28.99% | $6.80M | — | $7.43M | — | 05/13/2021 | Get Alert |
| CCCC | C4 Therapeutics | — | — | -$3.45 | — | — | — | $8.26M | — | 03/11/2021 | Get Alert |
| CCCC | C4 Therapeutics | -$8.93 | — | -$17.55 | — | $5.36M | — | $8.45M | — | 11/12/2020 | Get Alert |
C4 Therapeutics (CCCC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.49 | $-0.37 | -32.4 % |
| Q3 | 2024-10-31 | $-0.35 | $-0.38 | 7.89 % |
| Q2 | 2024-08-01 | $-0.26 | $-0.37 | 29.7 % |
| Q1 | 2024-05-08 | $-0.41 | $-0.35 | -17.1 % |
C4 Therapeutics (CCCC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $5.18M | $3.60M | 43.8 % |
| Q3 | 2024-10-31 | $15.36M | $4.60M | 234.0 % |
| Q2 | 2024-08-01 | $12.01M | $4.78M | 151.2 % |
| Q1 | 2024-05-08 | $3.04M | $8.10M | -62.5 % |
FAQ
When is C4 Therapeutics (NASDAQ:CCCC) reporting earnings?
C4 Therapeutics (CCCC) is scheduled to report earnings on July 31, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for C4 Therapeutics (NASDAQ:CCCC)?
The Actual EPS was $-0.49, which missed the estimate of $-0.37.
What were C4 Therapeutics’s (NASDAQ:CCCC) revenues?
The Actual Revenue was $5.2M, which beat the estimate of $3.6M.
Browse earnings estimates, EPS, and revenue on all stocks.
